325 related articles for article (PubMed ID: 31771069)
1. Relationships of Cerebrospinal Fluid Alzheimer's Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms.
Babić Leko M; Nikolac Perković M; Klepac N; Švob Štrac D; Borovečki F; Pivac N; Hof PR; Šimić G
J Alzheimers Dis; 2020; 73(1):135-145. PubMed ID: 31771069
[TBL] [Abstract][Full Text] [Related]
2. Association of MAPT haplotype-tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: A preliminary study in a Croatian cohort.
Babić Leko M; Willumsen N; Nikolac Perković M; Klepac N; Borovečki F; Hof PR; Sonicki Z; Pivac N; de Silva R; Šimić G
Brain Behav; 2018 Nov; 8(11):e01128. PubMed ID: 30329219
[TBL] [Abstract][Full Text] [Related]
3. Association of the MAOB rs1799836 Single Nucleotide Polymorphism and APOE ε4 Allele in Alzheimer's Disease.
Babić Leko M; Nikolac Perković M; Nedić Erjavec G; Klepac N; Švob Štrac D; Borovečki F; Pivac N; Hof PR; Šimić G
Curr Alzheimer Res; 2021; 18(7):585-594. PubMed ID: 34533445
[TBL] [Abstract][Full Text] [Related]
4. IL-1β, IL-6, IL-10, and TNFα Single Nucleotide Polymorphisms in Human Influence the Susceptibility to Alzheimer's Disease Pathology.
Babić Leko M; Nikolac Perković M; Klepac N; Štrac DŠ; Borovečki F; Pivac N; Hof PR; Šimić G
J Alzheimers Dis; 2020; 75(3):1029-1047. PubMed ID: 32390629
[TBL] [Abstract][Full Text] [Related]
5. A community-based study of cigarette smoking behavior in relation to variation in three genes involved in dopamine metabolism: Catechol-O-methyltransferase (COMT), dopamine beta-hydroxylase (DBH) and monoamine oxidase-A (MAO-A).
Shiels MS; Huang HY; Hoffman SC; Shugart YY; Bolton JH; Platz EA; Helzlsouer KJ; Alberg AJ
Prev Med; 2008 Jul; 47(1):116-22. PubMed ID: 18486967
[TBL] [Abstract][Full Text] [Related]
6. Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients.
Lanni C; Garbin G; Lisa A; Biundo F; Ranzenigo A; Sinforiani E; Cuzzoni G; Govoni S; Ranzani GN; Racchi M
J Alzheimers Dis; 2012; 32(4):919-26. PubMed ID: 22890094
[TBL] [Abstract][Full Text] [Related]
7. Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment.
Babić Leko M; Borovečki F; Dejanović N; Hof PR; Šimić G
J Alzheimers Dis; 2016; 50(3):765-78. PubMed ID: 26836160
[TBL] [Abstract][Full Text] [Related]
8. Modification of the association between early adversity and obsessive-compulsive disorder by polymorphisms in the MAOA, MAOB and COMT genes.
McGregor NW; Hemmings SMJ; Erdman L; Calmarza-Font I; Stein DJ; Lochner C
Psychiatry Res; 2016 Dec; 246():527-532. PubMed ID: 27821364
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.
Kiyohara C; Miyake Y; Koyanagi M; Fujimoto T; Shirasawa S; Tanaka K; Fukushima W; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
BMC Neurol; 2011 Jul; 11():89. PubMed ID: 21781348
[TBL] [Abstract][Full Text] [Related]
11. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
[TBL] [Abstract][Full Text] [Related]
12. DBH -1021C>T and COMT Val108/158Met genotype are not associated with the P300 ERP in an auditory oddball task.
Spronk DB; Veth CP; Arns M; Schofield PR; Dobson-Stone C; Ramaekers JG; Franke B; de Bruijn ER; Verkes RJ
Clin Neurophysiol; 2013 May; 124(5):909-15. PubMed ID: 23261162
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
Kettunen P; Larsson S; Holmgren S; Olsson S; Minthon L; Zetterberg H; Blennow K; Nilsson S; Sjölander A
J Alzheimers Dis; 2015; 44(4):1313-22. PubMed ID: 25420549
[TBL] [Abstract][Full Text] [Related]
14. Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson's disease in an Iranian population.
Torkaman-Boutorabi A; Ali Shahidi G; Choopani S; Reza Zarrindast M
Folia Neuropathol; 2012; 50(4):382-9. PubMed ID: 23319194
[TBL] [Abstract][Full Text] [Related]
15. The catechol-O-methyltransferase and monoamine oxidase B polymorphisms and levodopa therapy in the Iranian patients with sporadic Parkinson's disease.
Torkaman-Boutorabi A; Shahidi GA; Choopani S; Rezvani M; Pourkosary K; Golkar M; Zarrindast MR
Acta Neurobiol Exp (Wars); 2012; 72(3):272-82. PubMed ID: 23093014
[TBL] [Abstract][Full Text] [Related]
16. Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO): possible linkage between the ABO locus and a gene controlling DBH activity.
Goldin LR; Gershon ES; Lake CR; Murphy DL; McGinniss M; Sparkes RS
Am J Hum Genet; 1982 Mar; 34(2):250-62. PubMed ID: 6951409
[TBL] [Abstract][Full Text] [Related]
17. MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease.
Sampaio TF; Dos Santos EUD; de Lima GDC; Dos Anjos RSG; da Silva RC; Asano AGC; Asano NMJ; Crovella S; de Souza PRE
J Clin Pharmacol; 2018 Jul; 58(7):920-926. PubMed ID: 29578580
[TBL] [Abstract][Full Text] [Related]
18. Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease.
Mustapic M; Presecki P; Pivac N; Mimica N; Hof PR; Simic G; Folnegovic-Smalc V; Muck-Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():94-9. PubMed ID: 23416088
[TBL] [Abstract][Full Text] [Related]
19. Which Dopamine Polymorphisms Are Functional? Systematic Review and Meta-analysis of COMT, DAT, DBH, DDC, DRD1-5, MAOA, MAOB, TH, VMAT1, and VMAT2.
Tunbridge EM; Narajos M; Harrison CH; Beresford C; Cipriani A; Harrison PJ
Biol Psychiatry; 2019 Oct; 86(8):608-620. PubMed ID: 31303260
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
